Eva Maria Fenyö
11 – 20 of 73
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Inhibition of HIV-1 disease progression by contemporaneous HIV-2 infection.
(
- Contribution to journal › Article
- 2011
-
Mark
Reply to Redd et al
(
- Contribution to journal › Letter
-
Mark
Inhibition of splicing by serine-arginine rich protein 55 (SRp55) causes the appearance of partially spliced HIV-1 mRNAs in the cytoplasm
(
- Contribution to journal › Article
-
Mark
Sequence analysis of HIV-1 isolates from Guinea-Bissau: selection of vaccine epitopes relevant in both West African and European countries.
(
- Contribution to journal › Article
-
Mark
Human immunodeficiency virus type 1 biological variation and coreceptor use: from concept to clinical significance.
(
- Contribution to journal › Article
-
Mark
Increased Sensitivity to Broadly Neutralizing Antibodies of End-Stage Disease R5 HIV-1 Correlates with Evolution in Env Glycosylation and Charge.
(
- Contribution to journal › Article
- 2010
-
Mark
Enhanced CD4+cellular apoptosis by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with progressive HIV-1 infection
(
- Contribution to journal › Article
-
Mark
Frequent CXCR4 tropism of HIV-1 subtype A and CRF02_AG during late-stage disease - indication of an evolving epidemic in West Africa
(
- Contribution to journal › Article
-
Mark
Serine- and Arginine-rich Proteins 55 and 75 (SRp55 and SRp75) Induce Production of HIV-1 vpr mRNA by Inhibiting the 5 '-Splice Site of Exon 3
(
- Contribution to journal › Article
-
Mark
Increased sensitivity to neutralizing antibodies of end-stage disease R5 HIV-1 is concomitant with reduced gp120 glycosylation and increased plus charge
(
- Contribution to journal › Published meeting abstract